The VC Vodcast is our weekly digest on Venture Capital, based on curated content from our Newsletter, which goes is read ...
55 million people die every year from a life-threatening disease
55M people die every year from a serious disease. But did you know that over 10% of serious diseases have a genetic component and could have been prevented!
- 15% of all cancers have an inherited susceptibility
- 12% of all hospital admissions are a result of genetic causes
- 10% of all chronic diseases (diabetes, heart disease, Alzheimer's) have significant genetic components.
The problem is, we don’t have an efficient way to monitor genetic markers – we need a ‘minority report’ for health.
Predictiv is a DNA-based digital twin that assesses risks for 16K+ diseases
Predictiv is the future of medicine. Using DNA Next Generation Sequencing, we assess the level of risk on 16K+ diseases. In addition to that, we also sequence 20K+ genes and analyze 300+ drugs. Our DNA-based digital twin evolves, simulates reactions to 300+ drugs, presents real-time data and is completely searchable.
From your fingernail to your personalized preventive plan
- Everything starts with your DNA sample. After you receive your kit, just follow the instructions and send back your DNA sample (finger- or toenails).
- Once received, we extract your DNA, sequence it, and analyze it to create your Digital Twin.
- We then send you an invitation to take an online or face-to-face consultation with a genetic counselor who will take the time to get into details with you and set-up your personalized preventive plan.
Our genomics pipeline is 95%+ automated
Predictiv has spent 4 years developing the future of medicine. We now have an AI engine that was validated during the COVID-19 challenge organized in June/July 2020 with a genomics pipeline that is 95% automated. We also have filed two patents and have competed at the FDA challenge for COVID-19 data where we ranked 14th amongst the 35 major organizations participating, including Google, Accenture, and UCSF. We were 8th to predict the length of ICU hospitalization due to COVID-19.
We are currently discussing with more than 30 prominent organizations (healthcare providers, telemedicine companies...) who have shown great interest.
We are in final discussions for contracts covering 40,000 healthcare professionals and over 300 clinics in the USA, India and South East Asia. We expect those contracts to be signed soon and the first deployments to be started in March.
Helping patients and healthcare workers alike
Predictiv allows patients to assume full control over their genetic profile, empowering them to make accurate and recommended health decisions. Likewise, it allows healthcare workers access to early diagnoses and optimal drug doses and recommendations.
Predictiv costs $790 per unit, which includes Next Generation Sequencing and your consultation with a genetic counselor trained on our solution. We have created a mass-market solution that helps healthcare professionals, hospitals and governments address the genetic components of long-term and serious diseases.
Our solution can either be prescribed or recommended by a healthcare professional, or ordered directly on our website.
67% of US adults are interested in getting genetic testing to determine risks
67% of US adults are interested in getting genetic testing to determine risks. With the growing market for genetic testing and the billions of dollars spent on disease research, Predictiv projects $70M in revenue by 2024. We will only need 18 months to break even, and will have a 75% operating margin.
The most complete solution on the market
When current alternatives on the market have to research manually every time they want to cover a disease, our approach has been to screen them all and compare it to the 20,000 genes of your body. To our knowledge, we are the only solution to cover 99% of diseases known to have genetic components.
Thanks to our fully automated process, Predictiv provides information on 1,000 times more diseases than major solutions on the market!
Genetic testing and sequencing is just the start
Predictiv plans to provide health and analytical data on virtually all aspects of health. While we are starting with genomic sequencing and genetic testing, we plan to launch a fully scaled health and medical data platform, which will also bring the world of nutrition and fitness into the future.
Predictiv is asking $1M to launch the solution
Predictiv is asking for $1M to improve our UI/UX, execute partnerships in the USA and Asia, and expand our solution.
A team of experts & entrepreneurs
Founded by recognized genomics experts, Sajung and Sijung Yun, and a serial entrepreneur with 2 successful exits, Alex Rochegude, Predictiv has been built on the academic expertise and the entrepreneurship experience that is required to change the way medicine is done today.